Press releases

RaySearch Laboratories AB (publ) Interim Report January 1 – June 30, 2008

JANUARY 1 – JUNE 30, 2008
• Net sales for the period amounted to SEK 27.6 M (33.5)

• Profit after tax was SEK 4.2 M (10.7)

• Earnings per share amounted to SEK 0.12 (0.31)

• Operating profit amounted to SEK 4.4 M (14.3)

• Cash flow from operating activities amounted to SEK 5.4 M (19.8)

• Agreement with Philips regarding a new product for the new revolutionary treatment method VMAT.

• Agreement with Uppsala University Hospital regarding treatment planning system for proton therapy

• Agreement covering research cooperation within multi-criteria optimization with Massachusetts General Hospital in Boston, USA.

”We are far from satisfied with this profit level, but we strongly believe that the actions we have taken to strengthen sales of the released products will improve the situation. In addition, there are several new product releases scheduled in the coming year,” says Johan Löf, President of RaySearch.

”RaySearch’s guiding principle is to shorten the time required for new scientific discoveries to reach clinical application. Within the framework of our current business model we have several times experienced delays that are beyond RaySearch’s control. We have therefore started evaluating the possibility of selling direct to clinics in parallel with sales through our partners,” concludes Johan Löf.